39 results on '"Ahn, J.B."'
Search Results
2. The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression
3. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
4. 417P Randomized phase II trial of upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy versus preoperative chemoradiotherapy followed by surgery and adjuvant chemotherapy in locally advanced rectal cancer: KCSG-CO14-10
5. 324P Effects of screening and treatment improvement on colon cancer survival over 20 years in Korea
6. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
7. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
8. LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial
9. 618P Efficacy and safety of vactosertib and pembrolizumab combination in patients with previously treated microsatellite stable metastatic colorectal cancer
10. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
11. Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
12. The Benefit Of Locally Ablative Treatment In Lung Metastasis From Colorectal Cancer
13. 105P Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study
14. 417P Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer
15. A 30kVA superconducting generator development and basic tests
16. Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer (mCRC): A preplanned analysis of the phase III AXEPT trial
17. A phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy
18. Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup
19. Randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer (mCRC), comparing the efficacy and safety of XELIRI + bevacizumab versus FOLFIRI + bevacizumab (AXEPT)
20. Clinical manifestations and prognostic factors of bone metastasis in colorectal cancer
21. 88O - Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer (mCRC): A preplanned analysis of the phase III AXEPT trial
22. TERRA: a randomized, double-blind, placebo-controlled phase 3 study of TAS-102 in Asian patients with metastatic colorectal cancer
23. 160P Significance of serum carcinoembryonic antigen despite normal preoperative levels in colorectal cancer patients receiving curative resection
24. 568P - A phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy
25. LBA3_PR - Randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer (mCRC), comparing the efficacy and safety of XELIRI + bevacizumab versus FOLFIRI + bevacizumab (AXEPT)
26. 142O - Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup
27. 606P - Clinical manifestations and prognostic factors of bone metastasis in colorectal cancer
28. Metformin Use is Associated with Improved Survival in Diabetic Pancreatic Cancer Patients
29. 5 Synergistic anticancer effect of combination treatment with MEK inhibitor and PI3K inhibitor in castration-resistant prostate cancer
30. 465PD - TERRA: a randomized, double-blind, placebo-controlled phase 3 study of TAS-102 in Asian patients with metastatic colorectal cancer
31. Association Between CPG Island Methylator Phenotype (CIMP) and Treatment Response of Folfiri with Cetuximab in Patients with Metastatic Colorectal Cancer (MCRC)
32. P16(INK4A) Gene Hypermethylation and Kras Mutation are Independent Predictors of FolFiri and Cetuximab Chemotherapy in Patients with Metastatic Colorectal Cancer (MCRC)
33. 6111 POSTER Combining Capecitabine, Oxaliplatin and Gemcitabine (XELOXGEM) for Colorectal Carcinoma Patients Pretreated With Irinotecan -a Multicenter Phase l/lI Trial
34. 6055 A randomized phase II study of Xeloda with or without oxaliplatin as a first-line treatment in the elderly patients with metastatic colorectal cancer: Korean Cancer Study Group
35. ROLE OF ADJUVANT PELVIC RADIOTHERAPY IN RECTAL CANCER PATIENTS WITH SYNCHRONOUS LIVER METASTASIS
36. 699P - Metformin Use is Associated with Improved Survival in Diabetic Pancreatic Cancer Patients
37. A 30 kVA superconducting generator development and basic tests
38. Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases.
39. Development of high speed PMSM for distributed generation using microturbine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.